Dragonfly Therapeutics
Clinical trials sponsored by Dragonfly Therapeutics, explained in plain language.
-
New immune therapy tested in fight against advanced cancers
Disease control CompletedThis early-stage study tested a new drug called DF1001 in people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find a safe dose and see if the drug, given alone or with other cancer therapies, could help shrink tumors. The t…
Phase: PHASE1, PHASE2 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 05:42 UTC
-
New cancer drug targets immune system in early human trial
Disease control CompletedThis was an early-stage study to test a new drug called DF9001 in people with advanced solid tumors that have spread, returned, or cannot be removed by surgery. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked for early sign…
Phase: PHASE1, PHASE2 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First patients test experimental cancer drug in early safety trial
Disease control CompletedThis first-in-human study tested the safety of a new cancer drug called DF6215, both alone and combined with an existing immunotherapy (pembrolizumab), in adults with advanced solid tumors that couldn't be removed by surgery, had returned, or had spread. The main goals were to fi…
Phase: PHASE1 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
First test of new cancer fighter DF6002 shows early promise
Disease control CompletedThis first-in-human study tested a new drug called DF6002 in 170 patients with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find safe dose levels and see if the drug, given alone or with an existing immunotherapy (nivolumab), co…
Phase: PHASE1 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC